Yan et al. [24] found that EZH2 immunohistochemical expression was higher in papillary thyroid carcinoma (PTC) than in surrounding normal tissues, and there were significant differences between EZH2 and lymph node metastasis, extrathyroid involvement, and tumor multifocal growth in patients. Here, EZH2 is linked to thyroid gland papillary carcinoma.